Compound 1759
Identifiers
- Canonical SMILES:
NS(=O)(=O)c1ccc(OCCCN2CCC(CC2)[C@@](O)(c2cccc(F)c2)c2ccccn2)cc1
- IUPAC name:
4-(3-{4-[(3-fluorophenyl)(hydroxy)pyridin-2-ylmethyl]piperidin-1-yl}propoxy)benzenesulfonamide
- InChi:
InChI=1S/C26H30FN3O4S/c27-22-6-3-5-21(19-22)26(31,25-7-1-2-14-29-25)20-12-16-30(17-13-20)15-4-18-34-23-8-10-24(11-9-23)35(28,32)33/h1-3,5-11,14,19-20,31H,4,12-13,15-18H2,(H2,28,32,33)/t26-/m1/s1
- InChiKey:
INGQKBOOCCZMBG-AREMUKBSSA-N
External links
![]() 168317744 |
![]() CHEMBL3126200 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
MENIN / MLL | 6.83 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 499.19 g/mol | |||
HBA | 7 | |||
HBD | 3 | |||
HBA + HBD | 10 | |||
AlogP | 2.76 | |||
TPSA | 105.75 | |||
RB | 9 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5112 | Dianicline | DB12125 | |
0.4826 | Bepotastine | DB04890 | |
0.4546 | Mibefradil | DB01388 | |
0.4293 | Mapracorat | DB12041 | |
0.4286 | SCH-486757 | DB12782 | |
0.4277 | Nebivolol | DB04861 | |
0.4247 | Pheniramine | DB01620 | |
0.4229 | Ronacaleret | DB05255 | |
0.4228 | GLPG-0187 | DB12297 | |
0.4194 | ZK-806711 | DB03373 | |
0.4190 | Cebranopadol | DB12830 | |
0.4189 | Ramatroban | DB13036 | |
0.4186 | Meprotixol | DB13822 | |
0.4183 | (2R,3R)-7-(methylsulfonyl)-3-(2,4,5-trifluorophenyl)-1,2,3,4-tetrahydropyrido[1,2-a]benzimidazol-2-amine | DB07193 | |
0.4162 | Quinisocaine | DB13683 |